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The cyanation of 1-(2,3-epoxypropyl)uracil (VIII), followed 
by the ethainolysis of the resulting 3'-cyano compound VI (R=H)' 
to 3'-ethoxycarbonyl derivative VII (R=H), led to the synthesis 
of 1~(2,4-dihyd11oxybutyl)uracil (II, R and R1 =H). The oxidation 
of 1-allylumcil by KMn04 gave 1-(2,3-dihydroxypropyl)uracil (I, 
R=H) (Scheme 1). 
The intramolecular transformations of suitably activated I 
(R=H) were studied and the structures of the resulting 2,3-dihy-
dro-2-hydroxymethy l-7H-oxazolo [3,2-a] pyrimidin-7-one (X), 1 (2,3-
-d:ihydroxypropy 1)-2-0-methy luracil (XI) aind their mesyl, azido, 
and trityl derivatives are descibed (Scheme 2). In addition the 
2-azidomethyl- (XXI) was converted into 2--aminomethyl- (XXUI) 
2,3-dihydro-7H-oxazolo [3,2-a] pyrimidin-7-one. 
Recently we described the synthesis of 1-(2,3-dihydroxypropyl)uracil (I, 
R=H), 1-{2,3-dihydroxypropyl)thymine1 (I, R=Me), and the homologation of 
the latter into l-{2,4-dihydroxybutyl)thymine2 {II, R=Me and R1 =H) as part 
of our continuing interest in the structural, stereochemical and biochemical 
features of the dihydroxyalkyl nucleoside analogues and their relations to 
naturally occuring nucleosides3- 5• As we discussed in the previous paper6 the 
intramolecular transformations of the aliphatic thymidine analogue afforded 
a number of bicyclic products, which couM be related to the behaviour of 
the natural nucleosides. The present paper deals with the chemistry and 
intramolecular transformations of the suitably activated 1-(2,3-dihydroxypro-
pyl)uracil (I, R=H) (Scheme 1). 
Compared with the earlier reported oxidation of 1-allyluracil III into 
1-(2,3-dihydroxypropyl)uraciP (I, R=H) by the silver acetate-1odine method7, 
a partial o~rdation of III by KMn04 in water-acetone8 under carefully con-
trolled condiUons9•10 gave compound I (R=H) in much higher yields. 
Although the homologation of 1-(2,3-dihydroxypropyl)- {I, R=Me) into 
1-(2,4-dihydroxybutyl)-thymine (II, R=Me) was described to proceed succes-
sfully through the sequence of 3'-0-tosyl- (IV, R=Me), 3'-iodo- (V, R=Me), 
3'-cyano- (VI, R=Me), and 3'-ethoxycarbonyl- (VII, R=Me) derivatives2, we 
found it more convenient to prepare 1-(2,4-dihydroxybutyl)uracil (II, R=H) 
via the selective epoxrdation11 of 1-allyluracil (III) by m-chloroperbenzoic 
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(V) X= I 
(VI) X=CN----,v 
(VII) X = COzEt __J 
Reagents: i, 3.5'0/o KMn04 in H20-Me2CO at 10-15 °C; ii, m-Cl-PhC03H-
-CHC13 at 0 °C; iii, NaI-EtCOMe-HOAc; iv, KCN-500/o EtOH; v, 6 mol dm-3 
HCl in EtOH; vi , LiA1H4-THF; vii, Ac20-py. 
(KCN/500/o EtOH) of the thus obtained 1-(2,3-epoxypropyl)uracil (VIII and 
P~nner's ethanolysis14 (HCl/EtOH) of the resulting 1-(3-cyano-2-hydroxypro-
pyl)uracil (VI, R= H) into 1-(3-ethoxycarbonyl-2-hydroxypropyl)uracil (VII, 
R=H) (Scheme 1). The LiAlH4 reduction15 of the latter afforded the product 
II (R and R1=H) which was characterized as 1-(2,4-di-0-acetil-2,4-dihydroxy-
butyl)uracil (IX, R=H and R1 =Ac). The oxiran VIII, obtained in 740/o yield, 
deserves special mention as the crucial intermediate in the shortened homo-
logation sequence, but also as the required starting material for the synthesis 
of 1-(2-hydroxy-3-iodopropyl)uracil (V, R= H), which was earlier prepared! 
from the less accessible 1-(3-0-p-tolylsulphonyl-2,3-dihydroxypropyl)uracil (IV, 
R=H). 
In continuation of our studies on the intramolecular cyclisation reactions 
in the aliphatic thymidine analogues series6, treatment of 3'-0-tosyl- compound 
IV (R=H) with sodium methoxide effected transformations yielding 2,3-dihy-
dro-2-hydroxymethy 1-7H-oxazolo[3,2-a ]pyrimidin-7-one [2,2' -anhydro-1-(2,3-di-
hydroxypropy l)uracil (X)] (Scheme 2) (up to 330/o). The reaction time was 
shorter (3 h) than that required for the analogous conversion of the thymine 
derivative IV (R=Me) (30 h; 650/o of a single product; cf. ref. 6). This relatively 
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128 V. SKARIC AND M. JOKIC 
mediary oxiran VIII (up to 180/o) and 1-(2-3-dihydroxypropyl)-2-0-methyl-
uracil (XI) (up to 160/o), the latter being formed by concomitant ring opening 
of the 2,2'- X and, possibly, of the rather labile 2,3'- XII- anhydro compound. 
A similar reaction of 1-(2,3-dirriethylsulphonyloxypropyl)uracil (XIII) (Scheme 
2) with sodium methoxide in methanol yielded 2,3-dihydro-2-methylsulphonyl-
oxymethy 1-7H-oxazolo [3,2-a] pyrimidin-7-one (XIV, 280/o ), 1-(2-0-mety lsul pho-
ny l-2,3-dihydroxypropy 1)-2-0-methy luracil (XV, 33'0/o), and 1-(2,3-epoxypropyl)-
--2-0-methyluracil (XVI, 200/o) as the final products, the latter being formed 
from the intermediary 1-(3-0..,methylsulphonyl-2,3-dihydroxypropyl)-2-0-me-
thyluracil [XVII] . In comparison with the _ analogous thymine derivative6, the 
2',3'-dimesyloxy- co_mpound XIII afforded the 2,2'-anhydro compound XIV in 
lower yield, but also much faster 
ring opening of the thus formed bicyclic structure. On the other hand the 
2'-0-mesyl derivative XV, being formed from the insufficiently stable six-
-membered 2,3'-anhydro compound XVIII as the intermediate, was isolated 
in higher yields (330/o) than the corresponding derivative in the thymtne 
series (160fo)6. 
In evaluating th~ factors inducing the intramolecular cyclisations of 
compound I (R=H), 1-(3-azidu::.2-hydroxypropyl)macil (XIX), being prepared 
from IV (R=H) according to the procedure described by T. Sasaki et al.16, 
was activated in the for!n of 1~(3-a2;ido-2-methylsulphonyloxypropyl)uracil 
(XX). The latter in reaction with_ sodium methoxide readily cyclized yielding 
2-azidomethyl-2,3·dihydro-7H-oxazolo[3,2-a]pyrimidin-7-one (XXI) (180/o) and 
1-(3-azido-2-hydroxypropyl)2-0-methyluracil (XXII) (740/o) . The formation of 
compound XXII, which appeared to be due to concomitant methoxide ion 
attack at C-2 of the chemically sensitive 2,2'-anhydro compound XXI was 
shown to be dependent upon the time of reaction. 
2-Azidomethyl-2,3_-dihydro-7H-oxa:z;olo[3;2-a]'pyrimidin-7-one (XXI) (Sche-
me 2) was also prepared from the corresponding 2-mesyloxymethyl compound 
XIV by a reaction with sodium-azide J•n DMF16• Concerning the bicyclic product 
XXI, a catalytic (Pd-black) hydrogenolysis in methanol gave 2-aminomethyl-
-2,3-dihydro-7H-oxazolo[3,2-a]-pyrimidin-7-one (XXHI), which was characte-
rized as the benzamidomethyl derivative XXIV. 
In order to shed light on the formation and ring opening of the five-mem-
bered 2,2'-anhydro structures, 1-(3-0-triphenylmethyl-2,3-dihydroxypropyl)-
uracil (XXV) was conveniently mesylated to give 1-(2-0-methylsulphonyl-3-
-0-triphenylmethyl-2,3-dihydroxypropyl)uracil (XXVI). The thus C-2' activated 
derivative was treated with sodium methoxide in methanol or with sodium 
azide in DMF (vide infra) to give 2-triphenylmethyloxymethyl-2,3-dihydro-
-7H-oxazolo[3,2-a]pyrimidin-7-one (XXVII) in good yields (up to 670/o) . This 
finding indicated that the steric effect of the 3'-0-trityl group not only 
directs the 2;2·- cyclisation, but also increases the stability of the resulting 
3'-0-trityl-2,2'-anhydro structure XXVII. 
The observed cyclisation of compound XXVI, using sodium azide as 
reagent, was in good agreement with the observation that under similar 
conditions, 5'-0-acetyl-2'-0-tosyluridine gave the corresponding 2,2'-anhydro 
compound17 instead of the expected 2'-azido derivative. In our experiments, 
the expected 1-(2-azido-3-triphenylmethyloxypropyl)uracil (XXVIII) was iso-
lated as by-product (330/o). It is interesting to note that 1-(2-0-methylsulpho-
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nyl-2,3-dihydroxypropyl)uracil (XXIX), being obtained by the detrityl_ation of 
compound XXVI, afforded 1-(2-azido-3-hydroxypropyl)uracil (XXX) as the 
main reaction product. Compound XXX was conveniently converted into 
1-(2-azi:do-3-methylsulphonyloxypropyl)uracil (XXXI) . 
While the transformations of the 2'-activated derivatives involved already 
described 2,2'-anhydro compounds and controlled ring opening of the thus 
formed bicyclic intermediates, 3'-activated m esyl compound XXXI afforded 
1-(2-azido-3-hydroxypropyl)-2-0-methyluracil (XXXII) (560/o) as the single 
product (Scheme 2), through the thermodynamically less favoured 2,3'-anhydro 
intermediate XXXIII. The similar conversion of 1-(2-azido-3-iodopropyl)uracil 
(XXXIV) into compound XXXII by a treatment with silver acetate in metha-
nol proceeded in 500/o yield . The iodo compound XXXIV was prepared from 
2'-azido-3'-mesyloxypropyl derivative XXXI by a treatment with sodium 
iodide in butan-2-one. 
The stl'uctures of the 1-(2,3-dihydroxypropyl)uracil derivatives (XIII-
-XXXIV) and of the 2,2'-anhydro compounds (X-XXVII) reported here (see 
Table) were characterized by their NMR spectra. Thus, the vicinal coupling 
canstants J5•6 in the dihydroxypropyl derivatives XIII-XXXIV were around 
8 Hz1. It is interesting to note that the vicinal coupling constants J5,6 of 
the 2,2'-anhydro compounds X-XXVII were well defined and never larger 
than 7.3 Hz. While the C-6 resonances of the dihydroxypropyl compounds 
XIII-XXXIV (solution in DMSO-d6) consisted of two sharp Hnes (centred 
at r, 2.39-2.52), the C-5 protons (centred at r, 4.39-4.49) exhibited doublets 
(J = 7.6-7.9 Hz) with secondary splittings (1.6-2.1 Hz), as shown in the 
spectra of the compounds XIII, XXVI, XXVIII, XXIX, and XXXIV. This fin-
ding, in good accordance with an examination of the NMR spectrum of 1-me-
thyluracil18, arises from the long range interactions of the C-5 protons with the 
N-3 protons and the a W coupling19• It is worth noting that the C-5 proton 
of the 3'-azido-2'-hydroxypropyl compound XIX exhibited an extraordinary 
upfield shift, appearing as a doublet at r, 5.52 and that the C-6 protons of all 
anhydro compounds X-XXVII reported here showing practically constant 
chemical shifts at r, 2.26 and 2.28. 
The C-1' and C-3' geminal protons, near to the asymmetric C-2' centre, 
coupled with each other and each gave different coupling with the C-2' vicinal 
proton. These nonequivalences possibly resulted from unequal populations 
of conformers. Thus, the C-1' geminal protons of 2',3'-dihydroxypropyl deri-
vatives XIIl-XXXIV (with the exception of epoxy-compound VIII and azido 
derivatives XIX) exhibited two doubled doublets at r, 5.89-6.16 and 6.08-6.37 
for 1'-Ha and 1'-Hb, respectively. The 1'-Ha and 1'-Hb protons of the 2,2'-anhydro 
compounds, however, disclosed doubled doublets at r, 5.95-6.05 and 5.63-5.80, 
respectively, and smaller coupling constants for the geminal protons (9.5-10.3 
Hz) than those of the corresponding protons of the 2',3'-dihydroxypropyl deri-
vatives (13.7-14.7 Hz). As it was expected C-3' and C-2' protons showed 
marked dependences upon the nature of the C-3' and C-2' substituents. The 
most pronounced influence, disclosed on the shifts of the protons situated at 
the a-positions to mesyl groups (downfield) and trityl groups (upfield), were 
in good accordance with recently reported results1. 
TABLE 
NMR Spectra•·b ('t Values) 
Compound NH-3 H-6(d) (Jo,s=Jo.s) H-5(d) H-2'(m) 
a(dxd) 
(J1•a,2•) 
(VII) -l.23(s) 2.52 4.49 (obs.)* 6.19 
(7.8) (3.8) 
(VII)°·d 0.89br(s) 2.58 4.20(dxd) (obs.)* 5.8& 
(7.8) (1.9)" (2.7) 
(VIII) -l.34(s) 2.46 4.44 6.7-6.8 5.98 
(7.8) 3.4 
(IX)•,d 0.99br 2.86 4.31(dxd) 4.61-4.83 5.84 
(7.9) (1.9)" (3.2) 
(XIII) -l.35(dxd) 2.45 4.43(dxd) 4.82-4.94 5.89 
(JNH,5 2.0) (7.8) (2.0)" (3.9) 
<XV)r 2.66 4.22 5.10-5.31 5.86--
(7.6) 
(XV1)4 '" 2.84 3.98 6.72-6.82 5.69 
(7.6) (2.4) 
(XIX) -1.19br(s) 2.50 5.52 6.12-6.H 6.2 
(8.1) (3.7) 
(XX) -1.3br(s) 2.45 4.44 4.97-5.12 6.01--
(8.1) 
(XXV)d,b l.Obr(s) 2.86 4.46(dxd) 5.87 (m) 5.99 
(7.6) (1.5)" 
(XXVl)h -1.28(dxd) 2.44 4.48(dxd) 4.43-4.52 5.97---
(JNH,5 1.9) ('l.6) (1.9)" 
(XXVIIl)4 'h 1.13br(s) 2.92 4.4l(dxd) 5.97 •. 
(7.9) (1.6)" 
(XXIX) - l.28br(s) 2.46 4.45(dxd) 5.14-5.30 5.96 
(7.9) (1.9)" (3.8) 
(XXX) -1.31br(s) 2.41 4.42 6.09--(m) 
(7.9) 
(XXXI) -1.38br(s) 2.39 4.39 (obs.)* 6.04 
(7.9) (3.4) 
(XXXIV) -1.36br(s) 2.41 4.40(dxd) 5.88-5.98 6.04 
(7.9) (2.1)0 
(X) A) 2.28 4.23 4.88-5.11 6.0 
(7.3) (m) (6.6) 
(XIV) A) 2.26 4.18 4.60-4.84 6.01 
(7.3) (6.6) 
(XXI) A) 2.28 4.19 4.71-4.96 6.05 
(7.3) (6.6) 
(XXIV)h,t A) 2.28 4.22 4.71-4.96 5.95 
(7.3) (7.1) 
(XXVII)" A) (obs.)* 3.92 4.93-5.07 6.03 
(7.3) (5.6) 
• See introduction to Experimental. b Values for doublets (d), triplets (t), quartets (q) refe r 
to multiplet centres; (m) unresolved multiplets; coupling constants are given in H z. c OEt and 
OAc protons signals are not recorded. (obs.)* Obscured by those of other protons. • Solution 
H-1' b(clxd) a(dxd) H-3' b(dxd) OH-2' 0-3' 
(J 1•b,2·) (J3•a,2•) (J 3'b,2.) (JoH.2.) or (JoH.s·) or 
J gem. Jgem. [OMsMe-2'] [OMsMe-3'] 
6.55 (obs.)* 7.72 4.69(d) 
13.7 (8.6) 15.4 (8.2) (5.8) 
6.28 7.34 7.47 
14.2 (7.8) (4.1) 16.8 (8.5) 
6.28 7.18-7.27 (obs.)* 
14.7 (5.7) (m) 
6.35 (obs.) .. 
14.3 (7.9) 
6.08 5.46 5.6 
14.7 (7.8) (3.2) 11.7 (4.4) [6.78(s)] [6.71(s)] 
--(m) 6.02 6.32--(m) 6.44 [6.89(s)] 4.65(t) 
(5.6) 
6.40 7.10 7.44 
14.7 (6.1) (4.2) 4.4 (2.7) 
6.51 6.65 6.81 4.38br(s) 
13.7 (8.6) (3.7) 12.7 (6.1) 
--(m)--6.08 6.16 6.40 [6.79(s)] 
(3.7) 13.6 (5.1) 
6.37 6.79--(m) 6.84 7.05(d) 
14.7 (7.8) (4.6) 
---(m) --6.03 (obs.)* 
[6.91(s)] 
---(m)--6.48 6.59 6.81 
(3.5) 10.5 (5.7) 
6.20 6.30-6.37 6.49 [6.86(s)] 4.7l(t) 
14.3 (8.9) (m) 12.7 (5.7) (5.7) 
(m) (m) 6.61 4.76(t) 
(5.4) 
14.0 6.26 5. 75_:.5_ 78 13.3 5.61 
(7.2) (m) (6.5) [6.73(s)] 
(m)- -6.12 6.63 6.34 
(5.5) 14.4 (9.2) 
5.73 6.26--(m) 6.41 4.69(t) 
9.8 (9.4) (5.6) 
5.63 5.42--(m) 5.47 
10.3 (9.9) [6.74(s)] 
5.68 6.18--(m) 6.23 
10.3 (9.6) 
10.3 5.66 6.24--(m) 6.35 
(9.5) 
5.80 6.83 6.29 
9.5 (9.2) (3.1) 11.0 (3.4) 
in CDC!, . ,. Coupling constant Js.Nn· r r 6.13(s) and " r 5.94(s) for Me0-2. " Aromatic proton 
signals are not recorded. 1 't 1.13 ( t ; J 5.6) for NHCOph. A) Numbering according to the 
nomenclature fo r 2,2 ' -anhydro-structures. 
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EXPERIMENTAL 
Melting points, uncorrected, were taken on a Kofler hot stage. IR spectra were 
obtained for potassium bromide pellets or liquid films on a Perkin-Elmer 297 spe-
ctrophotometer. UV spectra were taken for solution in ethanol with a Perkin-Elmer 
124 spectrophotometer. NMR spectra were measured for solutions in DMSO on 
a »JEOL JNM-FX 100« FT-NNM spectrometer with tetramethylsilane as internal 
standard, unless otherwise stated. The silica gel (Merck HF254, type 60) for TLC 
and for preparative TLC was activated at 110 °c for 60 min. The products were 
developed in CH2Clz-MeOH (9 : 1) and recovered from TLC chromatographic plates 
with acetone, unless otherwise stated. The products were rendered visible by UV 
illumination. 
1-(2,3-Dihydroxypropyl)uracil (I, R=H) 
To a solution of 1-allyluraciP (III) (1.14 g, 7.5 mmol) in acetone (37 ml), collect 
at 10-15 °C, 3.50/o KMn04 in water (42 ml) was added dropwise for 5 min and stirred 
for an additional 5 min. A precipitate was the filtered off and then filtrate evaporated 
to dryness under reduced pressure. Preparative TLC [in CH2Clz-Me0H (8 : 2)] gave 
I (R = H) (842 mg, 600/o), m. p. 142-143 °c (from MeOH), identical (mixed m. p., IR, 
NMR spectra) with an authentic sample1• 
1-(2,3-Epoxypropyl)uracil (VIII) 
To a solution of m-chloroperbenzoic acid (207 mg, 1 mmol) in CHC13 (3 ml) , 
1-allyluraciP (Ill, R=H) (152 mg, 1 mmol) was added at O 0c and then the mixture 
was stirred at 3- 5 °C for 16 h. The solvent was removed under reduced pressure 
and the residue washed with n-hexane (3 x 10 ml). The product was purified by 
preparative TLC [in ether and then in acetone-ether (4: 6)] . Apart from the starting 
material (79 mg, Ry ca. 0.65), VIII (RF ca. 0.54) was separated in 740/o (60 mg) yield 
(based on the transformed starting material), m. p. 136-137 °c (from acetone-ether). 
Anal. C7HsN203 (168.15) calc'd: C 50.00; H 4.80; N 16.650/o 
found : C 50.23; H 4.66; N 16.360/o 
UV spectrum: Amax 267 nm (log i; 3.80). IR spectrum: JJmax 3440br, 3141, 3090, 3041, 
2921, 1708br, 1679, and 1657 cm-1• 
1-(2-Hydroxy-3-iodopropyl)uracil (V, R=H) 
To a solution of 1-(2,3-epoxypropyl)uracil (VIII) (33 mg, 0.19 mmol) in butan-
-2-one (3 ml), glacial acetic acid (0.26 ml) and NaI (77 mg, 0.5 mmol) were added. 
The mixture was heated under reflux for 2 h and then evaporated to dryness. The 
residue was dissolved in w ater and decolourized with 50/o aq. solution of sodium 
thiosulphate. This solution w as evaporated to dryness under reduced pressure and 
the r esidue triturated with MeOH. A precipitate was filtered off, and the filtrate 
concentrated to a small volume. Preparative TLC afforded V (R=H) (37 mg, 580/o), 
Ry ca. 0.56, m. p . 178-179 °c (from MeOH), identical (mixed m. p ., IR, NMR spectra) 
with an authentic sample2• 
1-(3-Cyano-2-hydroxypropyl)uraci l (VI, R = H) 
To a solution of 1-(2,3-epoxypropyl)uracil (VIII) (55 mg, 0.33 mmol) in 500/o 
ethanol (2 ml) KCN (63 mg, 0.98 mmol) was added and the mixture was stirred at 
room temperature for 3 h. The solvent was then r emoved under reduced pressure. 
Preparative TLC [in CH2Ch-MeOH (8: 2)] afforded VI (R=H) (29 mg, 45.50/o), 
R y ca. 0.38, m. p. 149-150 °c (from MeOH), identical (mixed m. p ., IR and NMR 
spectra) with an authentic sample2• 
1-(3-Ethoxycarbonyl-2-hydroxypropyl)uracil (VII, R=H) 
A solution of 1-(3-cyano-2-hydroxypropyl)uracil (VI, R=H) (168 mg, 0.86 mmol) 
was treated with anhydrous ethanolic 6 mol dm-3 HCl (26 ml) and worked up as 
described for the ethanolysis of the analogous thymine derivative VI (R = Me)2• 
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Preparative TLC afforded VII (R=H) (164 mg, 78.9°/o) , R F ca. 0.55, m. p. 103-104 °c 
(from methanol-ether-n-hexane). 
Anal. C10H14N20s (242.23) calc'd: C 49.58; H 5.83; N 11.570/o 
found: C 49.59; H 5.82; N 11.620/o 
UV spectrum: Amax 265 nm (log i; 3.95). IR spectrum: Vmax 3451br, 3093, 2981 , 1740, 
1693, and 1664 cm-1. 
1-(2,4-Di-0-acetyl-2,4-dihydroxypropyl)uracil (IX, R=H) 
To a suspension of LiAlH4 (102 mg, 2. 7 mmol) in anhydrous THF (13.5 ml) a 
solution of the 3' -ethoxycarbonyl derivative VII (R=H) (219 mg, 0.9 mmol) in 
anhydrous THF (13.5 ml) was added dropwise. The suspension was then stirred 
at room temperature for 2 h and worked up as for the preparation of 1- (2,4-dihy-
droxybutyl(thymine2 (II, R=Me). The residue, containing the 2',4'-dihydroxybutyl 
homologue (II, R = H) as raw material, was suspended in pyridine (20 ml) 
and treated with acetic acid anhydride (2 ml). The mixture was set aside at 
room temperature for 16 h and then evaporated to dryness. Preparative TLC [two 
developments in CH2Cl2-MeOH (95 : 5)] gave IX (R=H) (87 mg, 340/o), RF ca. 0.5, 
m . p. 95-96 °c (from methanol-ether-n-hexane). 
Anal. C12H16N20 6 (284.26) calc'd: C 50.57; H 5.67 ; N 9.860/o 
found : C 50.48 ; H 5.79; N 9.89°/o 
UV spectrum : Amax 264 nm (log s 3.98). IR spectrum: Vmax 3576, 3516, 3156, 3096, 
3048, 2976, 1752, 1726, 1708, 1686, 1656, and 1602 cm-1• 
2,3-Dihydro-2-hydroxymethyl-7 H-oxazolo[3,2-a]pyrimidin-7-one (X) 
A suspension of 1-(3-0-p-tolylsulphonyl-2,3-dihydroxypropyl)uracil1 (IV, R = H) 
(140 mg, 0.41 mmol) in anhydrous MeOH (2 ml) was treated with methanolic 0. 1 
mol dm-:i sodium methoxide (4.94 ml, 0.49 mmol), stirred at room temperature for 
3 h and then evaporated to dryness under reduced pressure. The residue was 
triturated with CH2Cl2. A precipitate was filtered off and the filtrate concentrated 
to a small volume which was subjected to preparative TLC [development in 
Me2CO-Me0H (8 : 2)]. It gave the product X at RF ca. 0.27, (23 mg, 33.20/o), 1-(2,3-
-dihydroxypropyl)-2-0-methyluracil (XI) at RF ca. 0.38 (13.0 mg, 15.90/o), and 1-(2,3-
-epoxypropyl-uracil (VIII) at RF ca. 0.79 (12.5 mg, 180/o). 
Data of X . M. p . 189-191 °c (from m ethanol-ether-n-h exane). 
Anal. C7HaN20 s (168.15) calc'd: C 50.00 ; H 4.80; N 16.550/o 
found: C 50.22 ; H 5.02 ; N 16.390/o 
UV spectrum: Xmax 227 and 259 nm (log i; 3.92 and 3.85). IR spectrum: Ama x 3200br, 
3080, 2930, 1680sh, 1661, 1572, and 1551 cm-1• 
Data of VIII. M. p. 135-137 °c (from acetone-ether), identical (mixed m . p., IR 
and NMR spectra) with that obtained from 1- allyluracil (Ill). 
Data of XI. An unstable oil. NMR spectrum: 1: 2.51 (lH, d , 6-H ; J s,s 7.6 Hz), 
4.25 (lH, d, 5-H; J 5 ,6 7.6 Hz), 4.92 (lH, d , 2'-0H; J oH,2• 4.9 Hz), 5.20 (UI, t , 3'-0H; 
J oH,3• 5.4 Hz), 6.13 (3H, s, 2-0Me). 
1-(2,3-Dimethylsulphonyloxypropyl)uracil (XIII) 
To a solution of 1-(2,3-dihydroxypropyl)uracil (I, R=H) (610 mg, 3.28 mmol) in 
freshly distilled and at 5 °C cooled pyridine (10 ml), methanesulphonylchloride (0.6 
ml, 7.94 mmol) was added and then stirred at 3-5 °c for 16 h . The mixture was 
then evaporated to dryness and the residue on trituration with MeOH (15 ml) gave 
a crystalline product (940 mg, 83.90/o), RF ca. 0.43, m. p. 158-159 °c (from H20). 
Anal. C9H14N20 8S 2 (342.35) calc'd: C 31.57 ; H 4.12; N 8.180/o 
found: C 31.43 ; H 4.19 ; N 8.350/o 
UV spectrum: Amax 262 nm (log ;; 3.91). IR spectrum: Vmax 3440br, 3022, 3002, 2923, 
1703, 1692, and 1675 inf. cm-1• 
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Treatment of 1-(2,3-Dimethylsulphonyloxypropyl)uraciL (XIII) with Sodium 
Methoxide 
A suspension of 2',3'-dimesyloxy-derivative XIII (171 mg, 0.5 mmol) in anhy-
drous MeOH (60 ml) was heated under reflux and then treated with methanolic 
0.1 mol dm-3 sodium methoxide (5.5 ml, .0.55 mmol). The mixture was stirred at 
room temperature for 3 h and · evaporated to dryness. The residue was triturated 
with CH2Ch (4 X 10 ml). A precipitate was filtered off and the filtrate evaporated 
to dryness. Preparative TLC (two developments) separated the starting material at 
R.r_ca. 0.43 (17 mg), 2,3-dihydro-2-methylsulphonyloxymethyl-7H-oxazolo-[3,2-a]pyri-
midin-7-one (XIV) at RF ca. 0.16 (31 mg, 28°/o), 1-(2-0-methylsulphonyl-2,3-dihydro-
xypropylJ-2-0-rnethyluracil (XV) at RF ca. 0.28 (42 mg, 33.60/o), and l-(2,3- epoxy-
propyl)-2-0 - methylura cil (XVI) at RF ca. 0.45 (18 mg, 22°/o) . The yields are based 
on the transformed starting material. · 
Data of XIV. M. p . 173-174 °C [from MeOH-H20 (9 : 1)] a nd then from ether. 
Anal. CsH10N205S (246.24) calc'd: C 39.01; H 4.09; N 11.370/o 
found: C 39.25; H 4.27; N 11.60°/o 
UV spectrum: Xrnax 227 and 257 nm (log E 3.70 and 3.62), J.min 241 nm (log s 3.50). 
IR spectrum: Vmax 3435br, 3088, 3025, 2960, 2935, 1697, 1663, 1660, 1653, 1635br, 1594, 
1550, and 1527br cm-1• 
Data of XV. M. p. 154-Hi5 °c (from MeOH-ether). 
Anal. CuH14N206S (278.28) calc'd : C 38.84; H 5.07; N 10.070/o 
found: C 39.00; H 5.21; N 9.960/o 
UV spectrum: Anrnx 233 and 255 nm (log /5 3.90 and 3.81), Amin 244 nm (log /5 3.79) . 
IR spectrum: Vmax 3392br, 3260br, 3020, 3008, 2963, 2923, 1656, 1650, 1610br, and 1522br 
cm-1• 
Data of XVI. M. p. 86-88 °c (from CH2Ch-n-he.xane) . 
Anal. CsH10N20a (182.18) calc'd: C 50.70; H 5.67; N 9.860/o 
found: C 50.48; I-I 5.79; N 9.890/o 
UV spectrum: Amax 233 and 255 nm (log E 3.90 and 3.81), Amin 244 nm (log E 3.79). 
IR spectrum Vmax 3456br, '3076, 3002, 2976, 1654, 1646, 1526, and 1561 cm-1• 
1-(3-Azido-2-hydroxypropyL)uracil (XIX) 
A solution of 1-(3-0-p-tolylsulphonyl-2,3-dihydrox ypropyl)uracil1 (IV, R=H) 
(170 mg, 0.5 mmol) in DMF (4 ml) was treated with NaN3 (97 mg, 1.5 mmol) according 
to the procedure described by T. Sasaki et al.16. The mixture was stirred and heated 
at 90 °c for 1 h, and then evaporated to dryness under reduced pressure. Prepara-
tive TLC afforded XIX (90 mg, 85.30/o), RF ca. 0.31 m. p. 135-137 °C (from methanol-
-ether-·n-hexane). 
Anal. C1l-I9N50 3 (211.18) calc'd: C 39.81; I-I 4:30; N 33.170/o 
· found : C 39.91; H 4.59; N 33.390/o 
UV spectrum: },111ax 266 nm (log E 3.95). IR spectrum: Vmax 3306br, 3160br, 3028br, 
2918, 2180, 2124, 2100, 1689br, 1675br, and 1624 cm-1. 
1-(3-Azido-2-methylsulphonyLoxypropyl)uraciL (XX) 
To a solution of 1-(3-azido-2-hydroxypropyl)uracil (XIX) (167 mg, 0.8 mmol) 
in pyridine (2.4 ml) , cooled at 3-5 °c, methanesulphonylchloride (0.08 ml, 1.04 mmol) 
was added. The mixture was stirred for 16 h and . then the solvent removed under 
reduced pressure. The residue on trit'uration with MeOH (2 x 5 ml) and ether (2 x 5 
ml) afforded a raw product (208 mg). It crystallized from water to give XX (149 
mg, 65.40/o), RF ca. 0.56, m. p. 158-159 °c. 
Anal. CsH11N50 5S (289.27) calc'd: C 33.21; H 3.83; N 24.210/o 
found: C 33.50; H 3.99; N 24.520/o 
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UV spectrum: Amax 264 nm (log :; 3.97) . IR spectrum: Ymax 3420br, 3150, 3100, 3021, 
2936, 2880, 2830, 2172, 2100, 1710br, 1662br, and 1620 cm-1. 
2-Azid omethyl-2 ,3-dihydro-7H-oxazolo[3 ,2-a]pyrimidin-7-one (XXI) 
A solution of 2,3-dihydro-2-methylsulphonyloxymethyl-7H-oxazolo[3,2- a]pyrim i-
din-7-one (XIV) (96 mg, 0.5 mmol) in DMF (6.2 ml) was treated with NaN316 (80 m g, 
1.23 mmol). The mix ture was stir r ed and heated at 90 °c for 1 h . The solvent was 
removed under reduced pressure and the residue triturated with CH2Ch. The 
methylene chloride solution w as evaporated to dryness and the residue subj ected 
to preparatin TLC [CH2Cl2- MeOH (8 : 2)] to _give XXI (61 mg, 75 .30/o) , Ric ca. 0.23, 
m . p . 131- 132 °c (from MeOH-ether) . 
Anal. C1H 1N 50 2 (1 93.17) calc'd : C 43.52; H 3.65; N 36.260/o 
foun d: C 43.43 ; H 3.91 ; N 36.080/o 
UV spectrum : lmax 227 and 258 nm (log Ii 3.85 and 3.77), J, min 241 n m (log o 3.65). 
IR spectrum : Ymax 3440br, 3018, 2935br, 2100br, 1661, 1656, 1648sh , 1630br, and 1520 
cm-1. 
Treatment of 1-(3-Azido-2-methylsulphonylox ypropyl)-uracil (XX ) w ith 
Sodium Methoxide 
a) A suspension of 3'-azido- 2'-0-mesyl compound (XX) (33 m g, 0.11 mmol) 
in anhydrous MeOH was heated under reflux and then treated with methanolic 
0.1 mol dm-3 sodium m ethox ide (1.2 ml, 0.12 mmol.) The solution was then stirred 
at room temperature fo r 70 h and evapora ted to dryness. P r eparative TLC separated 
1-(2-azidomethyl-2,3-dihydro-7H-oxazolo[3,2-a)pyrimidin-7-one (XX I ) at Rp ca. 0.23 
(4 mg, 18.20/o), m. p. 130-132 °c, identical (mixed m. p. , IR and NMR spectra) with 
an authentic sample. An oily and unstable fraction a t RF ca. 0.29 vvas identified 
a s 1-(3-azido- 2-hydroxypropyl) -2-0-methyluracil (XXII) (19 mg, 73.90/o). IR spectrum: 
Ymax 3304br, 3024, 2964, 2104 br, 1669, 1652, 1629br, and 1514 cm-1. NMR spectrum 
(in CDC13): -r: 2.74 (lH, d , 6-H ; h ,s 7.8 H z), 4.26 (lH, d, 5-H; h,a 7.8 H z), 4.97- 5.18 
(lH, m , 2'-0H, dissappearing in D20) , 6.02 (3H, s, 2-0Me). 
b) According to the procedure described under a) the suspension of 1- (3-azido-
- 2-methylsulphonylox ypropyl)-uracil (33 mg, 0.11 m m ol) in anh yd rous meth anol was 
heated under reflux and treated w ith 0.1 m ol dm-3 sodium methoxide (1.2 ml, 0.1 2 
mmol) for 30 min. It afforded the crystalline 2-azidomethyl-2,3-dihydro-7H- ox azolo-
-[3,2-a)pyrimidin-7-one (XXI) (9.5 mg, 43.10/o), R y ca . 0.23, m. p . 130- 132 °c and the 
oily 1-(2-hydroxy-3-azidopropyl)-2-0-methyluracil (XX II) (7.5 mg, 29.20/o), RF ca. 
0.25, both identical (IR and NMR spectra) with tha t obtained u nder a). 
2-Benzamidomethyl-2,3-dihydro-7H-oxazolo[3,2-a]pyr imidin-7-one (XXIV) 
A solution of 2-a zidomethyl-2,3-dihydro-7H-oxazolo[3,2- a]pyrimidin-7-one (XX!) 
(123 mg, 0.64 mmol) in MeOH (33 ml) w as stirred in a tmosphere of hydrogen 
(0.36 MPa) in presence of Pd-black (33 m g) for 3 h . The catalyst was filtered off 
through a short Celite column. The filt rate was evaporated to an oily residue which, 
as suspension in freshly distilled pyridine (5.8 ml) , w as t r eated w ith benzoic an-
hydride (157 mg, 0.69 mmol). The mix ture w as stirred at room tempera ture for 24 h. 
The solvent w as removed u nder reduced pressu re and the residue on trituration 
with ether (3 x 15 m l) affo r ded a product which w as pur ified by prepar ative TLC 
(recovery with MeOH). Yield 85 m g XXIV (49.20/o), RF ca . 0.11, m. p . 155-156 °C 
(from MeOH). 
Anal. C14H 13N30 3 (271 .27) calc'd : C 61.98 : H 4.83; N 15.490/o 
found : C 61.76; H 4.83; N 15.190/o 
UV spectrum: Xmax 227 and 255 inf. nm (log E 4.22 and 3.87) . IR spect rum: ?•max 
3258br, 3065, 3020, 2930, 1667, 1655, 1649, 1620, 1602, 1578, 1562, 1558, 1523, 1512, 753, 
707, and 688 cm-1• 
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1-(3-0-Triphenylmethyl-2,3-dihydroxypropyl)uracil (XXV) 
To a solution of 1-(2,3-dihydroxypropyl)uracil1 (I, R=H) (293 mg, 1.58 mmol) 
in anhydrous and freshly distilled pyridine (9 ml) chlorotriphenylmethane20 (536 
mg, 1.93 mmol) was added. The mixture was stirred at 100 °c for 3 h, and then 
the solvent was azeotropically removed under reduced pressure in the presence of 
toluene. The residue was dissolved in chloroform and chromatographed through 
a silica gel (20 g) column. CHC13-MeOH (98 : 2) eluted XXV (621 mg, 91.8°/o), Rp ca. 
0.21 [in CH2Cl2-ether (3 : 1)], m. p. 109-110 °c (from MeOH). 
Anal. C25H24N204·H20 (446.48) calc'd: C 69.95; H 5.87; N 6.27°/o 
found: C 70.30; H 5.65; N 6.21 O/o 
UV spectrum: Aini 233 and Amax 265 nm (log s 3.97 and 4.02) , Amin 243 nm (log c 3.70). 
IR spectrum: Vmax 3500br, 3231br, 3055, 3030, 2960, 2920, 1705, 1690, 1677br, 1667, 
1635, 1603, 750, 704, and 696 cm-1. 
1-(2-0-methylsulphonyl-3-0-triphenylniethyl-2 ,3-dihydroxypropyl)uracil 
(XXVIJ 
To a solution of 1-(3-0-trityl-2,3-dihydrox ypropyl)uracil (XXV) (286 mg, 0.67 
mmol) in anhydrous and freshly distilled pyridine (3 ml) methanesulphonylchloride 
(0.08 ml, 1.1 mmol) was added. The mixture was stirred at room temperature for 
4.5 h. The solvent was then azeotropically removed under redu'ced pressure in the 
presence of toluene. The residue was dissolved in methylene chloride and chro-
matoraphed through a silica gel (10 g) column. Methylene chloride eluate afforded 
XXVI (313 mg, 92.60/o), Ric ca. 0.67, m. p. 180-181 °C (from MeOH) . 
AnaL C21H2aN205S (506.56) calc'd: C 64.01; H 5.17; N 5.530/o 
found: C 63.80; H 5.10; N 5.370/o 
UV spectrum: Aini 233 and Amax 262 nm (log :o 3.99 and 4.06), Amiu 242 nm (log c 3.80). 
IR spectrum: Ymax 3420br, 3157, 3052, 3020br, 2997, 2927, 17113, 1671, 1622, 748, 727, 
703, and 692 cm-1. 
2,3-Dihydro-2-triphenylmethyloxymethyl-7H-oxazolo[3,2-a]-pyrimidin-7-one 
(XXVIIJ 
To a suspension of 1-(2-mesyloxy--3-trityloxypropyl)-uracil (XXVI) (63 mg, 0.12 
mmol) in anhydrous MeOH (1 ml) methanolic 0.1 mol dm-3 sodium methoxide (1.7 
ml, 0.17 mmol) was added and stirred at room temperature for 24 h. The solvent 
was then removed under reduced pressure and the residue triturated with CH2Cl2 
(4 x 5 ml). The precipitate was filtered off and the filtrate evaporated to dryness. 
Preparative TLC [in CH2Ch-ether (1 : 1)] afforded XXVII (34 mg, 66.70/o), R~, ca. 
0.60, m. p . 113-115 °c (from MeOH). 
AnaL C26H22N20a·0.5 H20 (419.45) calc'd: C 74.46; H 5.53; N 6.68°/o 
found: C 73.99; H 5.51; N 6.560/o 
UV spectrum: Aini 221 and J. max 258 nm (log c 4.24 and 3.84), J,1i1 in 245 nm (log c 3.74). 
IR spectrum Vmax 3416br, 3058, 3036, 2924, 1656br, 1646, 1626, lGHi, 1596, 746, 709, 
and 696 cm-1. 
Treatment of 1-(2-0-M esyl-3-0-trityl-2 ,3-dihydroxypropyl)uracil (XXVIJ 
with Sodium Azide 
To a solution of 2'-0-mesyl-3'- 0-trityl derivative XXVI (180 mg, 0.36 mmol) 
in DMF (6 ml) NaNa (46 mg, 0.72 mmol) was added and worked up as described 
for 3'-azido-2'-0-mesyl compound XX. The preparative TLC [two developments in 
CH2Ch-MeOH (95 : 5)] separated an oily product at Rp ca. 0.75 (52 mg, 32.50/o), 
which was rechromatographed on preparative TLC plates and identified as 1-(2-
-azido-3-triphenylmethyloxypropyl)uracil (XXVIII) . 
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Anal. C2sH2aNsOa (453.38) calc'd : C 68.86; H 5.11; N 15.450/o 
found: C 68.57; H 5.20; N 15.460/o 
UV spectrum: Aini 233 and },max 264 nm (log s 3.87 and 3.92), Amin 243 nm (log s 3.60). 
IR spectrum: Ymax 3176br, 3090, 3056, 3028, 2122, 2100, 1710, 1686br, 1652, 1626, 750, 
741, 702, and 696 cm-1• 
The fraction, Rv' ca. 0.60, was identified as 2,3-dihydro-2-triphenylmethyloxy-
methyl-7H-oxazolo[3,2-a]pyrimidin-7-one (XXVII) (92 mg, 62.70/o), m. p. 113- 115 °c, 
identical (mixed m. p. , IR and NMR spectra) with an authentic sample. 
1-(2-0-M ethylsulphonyl-2,3-dihydroxypropyl)uracil (XXIX) 
A solution of 1-(2-0-mesyl-3-0-trityl-2,3-dihydroxypropyl)uracil (XXVI) (998 
mg, 1.95 mmol) in dioxan (19 ml) was treated with 50/o HCl (15.8 ml). The mixture 
was stirred and heated at 70 °C for 1 h. The solvent was removed under reduced 
pressure and the residue on trituration with CH2Cl2 afforded XXIX which crystal-
lized from MeOH. Yield 449 mg (90.20/o), RF ca. 0.32, m. p. 151-152 °c (from MeOH). 
Anal. CsH12N20oS (264.26) calc'd: C 36.36; H 4.58; N 10.600/o 
found: C 36.48; H 4.77; N 10.540/o 
UV spectrum: Amax 263 nm (log s 4.02). IR spectrum: Ymax 3447br, 3182, 3103, 3057, 
3015, 2937, 1704, 1690br, 1653, and 1627 cm-1• 
1-(2-Azido-3-hydroxypropyl)uracil (XXX) 
a) A solution of 1-(2-0-mesyl-2,3-dihydroxypropyl)-uracil (XXIX) (90 mg, 
0.34 mmol) in DMF 53 ml) was treated with NaN316 (66 mg, 1.02 mmol) . The mixture 
was stirred and heated at 90 °c for 2.5 h. A precipitate was filtered off and washed 
with CH2Cl2. The filtrate and CH2Ch washings were evaporated to dryness under 
reduced pressure. Preparative TLC afforded the oily product XXX (35.2 mg, 49.20/o), 
which was rechromatographed as analytical sample, RF ca. 0.44. 
Anal. C1H9N50 3 (211.18) calc'd: C 39.81; H 4.30; N 33.170/o 
found: C 39.50; H 4.50; N 32.940/o 
UV spectrum: Amax 264 nm (log s 4.12) . IR spectrum: Ymax 3436br, 2107, and 1683br 
cm-1• 
b) A solution of 1-(2-azido-3-trityloxypropyl)uracil (XXVII) (84 mg, 0.18 mmol) 
in dioxan (2 ml) was treated with 50/o HCl (1.5 ml). The mixture was stirred and 
heated at 60 °c for 30 min and evaporated to dryness under reduced pressure. Pre-
parative TLC afforded XXX (36 mg, 920/o), RF ca. 0.44, identical (IR and NMR 
spectra) with that obtained under a). 
1-(2-Azido-3-methylsulphonyloxypropyl)uracil (XXXI) 
To a solution of 1-(2-azido-3-hydroxypropyl)uracil (XXX) (178 mg, 0.85 mmol) 
in anhydrous and freshly distilled pyridine (4 ml) methanesulphonylchloride (0.1 
ml, 1.39 mmol) was added. The mixture was stirred at 3-5 °c for 16 h and worked 
up as already described. Preparative TLC (two developments) gave XXXI (209 mg, 
85.50/o), RF ca. 0.63, m. p. 115-116 °c (from MeOH). 
Anal. CsH11NsOsS (289.27) calc'd : C 33.21; H 3.83; N 24.210/o 
found: C 33.52; H 3.94; N 24.160/o 
UV spectrum: Amax 263 nm (log s 4.00). IR spectrum: Ymax 3242, 3050, 3032, 2967, 
2947, 2137, 2100sh, 1715, 1687br, and 1640 cm-1• 
1-(2-Azido-3-h ydroxypropy l)-2-0-methyluracil (XXXII) 
a) A solution of 1-(2-azido-3-mesyloxypropyl)uracil (XXXI) (78 mg, 0.27 mmol) 
in anhydrous MeOH (1.2 ml) was treated with methanolic 0.1 mol dm-3 sodium 
methoxide (2.83 ml, 0.28 mmol). The mixture was stirred at room temperature for 
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30 min and then evaporated to dryness. Preparative TLC afforded XXXII (34 mg, 
560/o), RF ca. 0.29, m. p. 97-99 °c (from methanol-ether-n -hexane). 
Anal. CsH11N503 (225.21) calc'd: C 42.66; H 4.92 ; N 31.100/o 
found: C 42.84; H 4.90; N 31.060/o 
UV spectrum: J,max 228 and 251 nm (log < 4.05 and 3.97), Amin 24i nm (log E 3.94). 
IR spectrum: l'max 3146br, 3015, 2961, 2937, 2134, 2085, 1654br, and 1617 cm-1. NMR 
spectrum: r 2.42 (lH, d, 6-H; J6,5 7.8 Hz), 4.18 (lH, d, 5-H; h ,6 7.8 Hz) , 4.68 (lH, t, 
3'-0H ; J oH,3' 5.4 Hz), 6.11 (3H , s, 2-0Me). 
b) A solution of 1-(2-azido-3-iodopropyl)uracil (XXXIV) (65 mg, 0.29 mmol) 
in anhydrous methanol was treated with AgOAc (137 mg, 0.81 mmol), stirred, and 
heated under reflux for 15 min. A precipitate was filtered off and the excess of 
Ag ion removed from the filtrate by precipitation with H 2S and then filtered 
through a short Celite column. The thus obtained filtrate was concentrated. Pre-
parative TLC separated XXXII (22.5 mg, 49.40/o), RF ca. 0.29, m. p. 97-99 °c, 
identical (mixed m . p., IR and NMR spectra) with that obtained under a). 
1-(2-Azido-3-iodopropyl)uracil (XXXIV) 
To a solution of 1- (2-azido-3-mesyloxypropyl)uracil (XXXI) (78 m g, 0.27 mmol) 
in butan-2-one (12 ml) NaI (188 mg, 1.26 mmol) was added. The mixture was stirred 
and h eated under reflux for 2.5 h. A precipitate was filtered off on a short Celite 
column and the filtrate evaporated to dryness under reduced pressure. Preparative 
TLC afforded XXXIV (70 mg, 80.80/o), Rr•' ca. 0.65, m. p. 138-139 °c (from MeOH). 
Anal. C1HsINs02 (321.09) calc'd: C 26.18; H 2.51; N 21.810/o 
found: C 26.30; H 2.63; N 21.480/o 
UV spectrum: Amax 264 nm (log < 4.01). IR spectrum: Ymax 3418br, 3158, 3103, 3032br, 
2966, 2938, 2120, 2094, 2078, 1722, 1657br, and 1610 cm-1• 
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SAZETAK 
Homologizacija i intramolekularne ciklizacije u scriji alifatskih analoga deoksiuridina 
Vinko Skaric i Milan Jakie 
Cijanizacija 1-(2,3-epoksipropil)uracila (VIII) i etanoliza nastalog 3'-cijano spoja 
VI (R=H) do 3'-etoksikarbonil derivata VII (R=H) vodi sintezi 1-(2,4-dihidroksi-
butil)-uracila (II, R i R1 =H). Oksidacija 1-aliluracila sa KMn04 daje 1-(2,3-dihi-
droksipropil)uracil (I, R=H) (Shema 1). 
Opisane su intramolekulske transformacije prikladno aktiviranog I (R = H) kao 
i tako nastale stmkture 2,3-dihidro-2-hidroksimetil-7H-oksazolo[3,2-a]pirimidin-7-ona 
(X), l -(2,3 -dihidroksipropil)-2-0-metiluracila (XI), te njihovih mezil-, azido- i tritil-
-derivata (Shema 2). 2-Azidometil-(XXI) uspjesno je preveden u 2-aminometil-
-(XXIII) 2,3- dihidro-7H-oksazolo[3,2-a]pirimidin-7-on. 
